Retracted: Parallel CD19/CD20 CAR-Activated T-Cells Are More Effective for Refractory B-Cell Lymphoma In Vitro and In Vivo

Detalles Bibliográficos
Autor principal: and Alternative Medicine, Evidence-Based Complementary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307390/
https://www.ncbi.nlm.nih.gov/pubmed/37387854
http://dx.doi.org/10.1155/2023/9824923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10307390/
https://www.ncbi.nlm.nih.gov/pubmed/37387854
http://dx.doi.org/10.1155/2023/9824923

Ejemplares similares